Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate ...

Dr. Donald Gleason. In medicine, technological advances and breakthroughs happen at lightning-paced speeds. But in the realm of prostate cancer, one major development, the Gleason grading system for ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

The researchers studied 62,839 people diagnosed with non-metastatic prostate cancer in Sweden between the years 2000-2020. All were placed within a defined risk category, had a life expectancy of more ...

Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).

Worldwide, prostate cancer is one of the main cancers affecting men. The final diagnosis of prostate cancer is based on the visual detection of Gleason patterns in prostate biopsy by pathologists.

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes ...

Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for to help catch it before it ...

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...